Porvair Sciences are teaming up with Suzhou Tianlong Bio Technology Co Ltd, together with Swansea University and Xi’an Jiaotong University in a collaborative project entitled, ‘”Automating & Stratification of Epigenetics in Healthcare’ that is part of the Innovate UK/Jiangsu Industrial Challenge Programme.
The project will integrate Porvair’s innovative solid-state chromatin immunoprecipitation platform, Chromatrap® with Tianlong’s expertise in automated robotic technologies and diagnostic multiplex PCR kits to develop innovative technologies in epigenetic characterisation for patient stratification in renowned precision medicine. Academics in cancer epigenetics from Swansea University and Xi’an Jiaotong University will support the project by providing insights and direction for the application in cancer research and drug development.
Dr Amy Beynon, Technical and Business Development Manager at Porvair Sciences said: “Developing new technologies to simplify and advance epigenetics research is the driving force here at Porvair. Combining Chromatrap with Tianlong’s expertise in diagnostic multiplex arrays, we will provide a streamlined workflow across both research and clinical applications. The ultimate collaborative goal is to provide innovative tools that improve diagnostic options for patients and informed novel stratified therapeutics.”